Trial intelligence / Profile preview

Prednisone prephase with or without vitamin D before immunochemotherapy in elderly DLBCL

2019-004474-26Phase 3Active

Sponsor
Fondazione Italiana Linfomi
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of cholecalciferol in diffuse large B-cell lymphoma (DLBCL) (2 arms), sponsored by Fondazione Italiana Linfomi. Primary endpoint: Primary safety of vitamin D supplementation. Started Oct 2020; status: active.

02

Drugs

cholecalciferol
03

Conditions

diffuse large B-cell lymphoma (DLBCL)

Beyond the preview

Go deeper on 2019-004474-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-004474-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call